bluebird bio Inc $ 89.55 0.77 (0.87%)
Volume:
610,910
Avg Vol (1m):
645,487
Market Cap $:
4.95 Bil
Enterprise Value $:
3.89 Bil
P/E (TTM):
0.00
P/B:
3.00
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
|
Price: $89.55 | ||
Manual of Stocks™ Web
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 6.46 | ||
| Equity-to-Asset | 0.81 | ||
| Debt-to-Equity | 0.12 | ||
| Debt-to-EBITDA | -0.29 | ||
| Piotroski F-Score | 3 | ||
| Altman Z-Score | 5.91 | ||
| Beneish M-Score | -0.67 | ||
| WACC vs ROIC | |||
Profitability | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -1199.09 | ||
| Net Margin % | -1158.04 | ||
| ROE % | -37.41 | ||
| ROA % | -31.12 | ||
| ROC (Joel Greenblatt) % | -257.29 | ||
| 3-Year Revenue Growth Rate | 37.2 | ||
| 3-Year EBITDA Growth Rate | -32.3 | ||
| 3-Year EPS without NRI Growth Rate | -30.5 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 3 | ||
| PS Ratio | 86.45 | ||
| EV-to-EBIT | -5.74 | ||
| EV-to-EBITDA | -5.88 | ||
| EV-to-Revenue | 68.81 | ||
| Current Ratio | 8.02 | ||
| Quick Ratio | 8.02 | ||
| Days Sales Outstanding | 138.63 | ||
| Days Payable | 5 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 3.05 | ||
| Price-to-Median-PS-Value | 0.57 | ||
| Earnings Yield (Greenblatt) % | -17.44 |